Impact of baseline gastric emptying on effects of lixisenatide and liraglutide in type 2 diabetes mellitus (T2DM) as add-on to insulin glargine

被引：0
|
作者：
Menge, B. A. [1 ]
Kapitza, C. [2 ]
Hincelin-Mery, A. [3 ]
Roy-Duval, C. [3 ]
Delfolie, A. [3 ]
Coester, H. -V. [4 ]
Forst, T. [4 ]
Meier, J. J. [1 ]
机构：
[1] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[2] Profil Inst, Neuss, Germany
[3] Sanofi R&D, Chilly Mazarin, France
[4] Profil Inst, Mainz, Germany
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
75
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [1] Lixisenatide as add-on to insulin glargine for the treatment of type 2 diabetes mellitus
    Forst, Thomas
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (12) : 1703 - 1708
  • [2] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
    Fonseca, Vivian
    Dejager, Sylvie
    Albrecht, Diego
    Shirt, Lynda
    Schweizer, Anja
    [J]. DIABETES, 2006, 55 : A111 - A111
  • [3] Effect of Lixisenatide vs. Liraglutide on Glycemic Control, Gastric Emptying, and Safety Parameters in Optimized Insulin Glargine T2DM ± Metformin
    Meier, Juris
    Rosenstock, Julio
    Hincelin-Mery, Agnes
    Royduval, Christine
    Delfolie, Astrid
    Coester, Hans-Veit
    Forst, Thomas
    Kapitza, Christoph
    [J]. DIABETES, 2014, 63 : A262 - A262
  • [4] Effect of lixisenatide vs liraglutide on glycaemic control, gastric emptying and safety parameters in optimised insulin glargine type 2 diabetes mellitus ± metformin
    Meier, J. J.
    Rosenstock, J.
    Hincelin-Mery, A.
    Roy-Duval, C.
    Delfolie, A.
    Coester, H. -V.
    Forst, T.
    Kapitza, C.
    [J]. DIABETOLOGIA, 2014, 57 : S377 - S378
  • [5] Effects of Insulin Glargine vs Thiazolidinediones on Glycemic and Lipid Variables in Type 2 Diabetes Mellitus (T2DM): The Impact of Obesity
    Meneghini, Luigi F.
    Rosenberg, Noah
    Hollander, Priscilla
    Rosenstock, Julio
    Riddle, Matthew C.
    Nesto, Richard W.
    Dandona, Paresh
    [J]. DIABETES, 2009, 58 : A523 - A523
  • [6] Physiologic Dose Response Effects of Insulin Glargine in Type 2 Diabetes (T2DM
    Wang, Zhihui
    Briscoe, Vanessa J.
    Hedrington, Maka S.
    Gogitidze, Nino
    Richardson, Antoinette
    Ertl, Andrew C.
    Davis, Stephen N.
    [J]. DIABETES, 2009, 58 : A150 - A150
  • [7] Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes
    Ericsson, Asa
    Glah, Divina
    Lorenzi, Maria
    Jansen, Jeroen P.
    Fridhammar, Adam
    [J]. PLOS ONE, 2018, 13 (02):
  • [8] Efficacy and Safety of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) for Type 2 Diabetes Mellitus (T2DM)
    Ford, Daniel M.
    Baz-Hecht, Merav
    Said, Nabil A.
    Tao, Ben
    Truitt, Kenneth E.
    Chou, Hubert S.
    [J]. DIABETES, 2013, 62 : A273 - A273
  • [9] Ramate as add-on to metformin (MET) in obese subjects with type 2 diabetes (T2DM)
    Toplak, H
    Vercruysse, F
    Sun, X
    Fitchet, M
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S159 - S159
  • [10] Lixisenatide: A guide to its use as add-on therapy in type 2 diabetes mellitus
    Lyseng-Williamson K.A.
    Scott L.J.
    [J]. Drugs & Therapy Perspectives, 2013, 29 (9) : 253 - 259
12345